dod dsip Capturing Non-Dilutive Funding from Department of Defense: SBIR Program Overview (Part I of III) dsip portal Capturing Non-Dilutive Funding

The difference between a researcher who gets consistent, potent results across a full protocol and one who sees diminishing effects by week three often comes down to storage

Here are answers to the most common dosage and protocol concerns people have when starting BPC-157

Because the core mechanism papers were retracted, even the premise that Dihexa potently engages HGF/c-Met in a living human brain at community-reported doses is not established fact

27 August 2015

Almeida VN (2024) Somatostatin and the pathophysiology of Alzheimers disease

Public Health Implications The FDA review presents a challenging dilemma for public health in the United States